Reference
Abuhelwa Z. Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review Drugs : 7 Jul 2022. Available from: URL: https://doi.org/10.1007/s40265-022-01736-w
Rights and permissions
About this article
Cite this article
Trastuzumab deruxtecan: risk of interstitial lung disease/pneumonitis. Reactions Weekly 1915, 10 (2022). https://doi.org/10.1007/s40278-022-19039-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-19039-9